InvestorsHub Logo

Smallville

03/13/18 9:55 AM

#133461 RE: Mistafixit #133456

Safety study was completed in 2017?

Can you provide a link to the results?

If they are going the drug route the product won't be available for many years.

The efficacy study was NOT done on actual patients.

moxa1

03/13/18 10:00 AM

#133470 RE: Mistafixit #133456

I think that is inaccurate. I believe the IRB safety study is due for completion by the end of Q1 which would be in two weeks or so. Once completed it would probably be announced. That is a potential big catalyst for us. That safety study could make the cream eligible for compounding in pharmacies, allowing it to be sold as a drug. It would also be a necessary component for any licensing deals IMO.

gruber72

03/13/18 11:49 AM

#133542 RE: Mistafixit #133456

Very good points. And why would they go to the trouble and expense of recruiting world class talent if they thought there were problems or if they didn't have something good in the works? The answer is; they wouldn't.

Mistafixit

03/13/18 11:56 AM

#133547 RE: Mistafixit #133456

Sorry meant to say efficacy study not safety, expecting that soon. Owcp